483 related articles for article (PubMed ID: 3040856)
1. Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein.
Bich-Thuy LT; Dukovich M; Peffer NJ; Fauci AS; Kehrl JH; Greene WC
J Immunol; 1987 Sep; 139(5):1550-6. PubMed ID: 3040856
[TBL] [Abstract][Full Text] [Related]
2. IL-2 receptors on circulating natural killer cells and T lymphocytes. Similarity in number and affinity but difference in transmission of the proliferation signal.
Ben Aribia MH; Moiré N; Métivier D; Vaquero C; Lantz O; Olive D; Charpentier B; Senik A
J Immunol; 1989 Jan; 142(2):490-9. PubMed ID: 2783438
[TBL] [Abstract][Full Text] [Related]
3. A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors.
Dukovich M; Wano Y; Le thi Bich Thuy ; Katz P; Cullen BR; Kehrl JH; Greene WC
Nature; 1987 Jun 11-17; 327(6122):518-22. PubMed ID: 3108674
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D
J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412
[TBL] [Abstract][Full Text] [Related]
5. Expression and the functional role of a p70/75 interleukin 2-binding molecule in human B cell.
Saiki O; Tanaka T; Doi S; Kishimoto S
J Immunol; 1988 Feb; 140(3):853-8. PubMed ID: 2828472
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
Weil-Hillman G; Voss SD; Fisch P; Schell K; Hank JA; Sosman JA; Sugamura K; Sondel PM
Cancer Res; 1990 May; 50(9):2683-91. PubMed ID: 1691679
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 2 functions through novel interleukin 2 binding molecules in T cells.
Tanaka T; Saiki O; Doi S; Negoro S; Kishimoto S
J Immunol; 1988 Jan; 140(2):470-3. PubMed ID: 2826593
[TBL] [Abstract][Full Text] [Related]
8. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.
Waldmann TA; Tsudo M
Prog Clin Biol Res; 1988; 262():283-93. PubMed ID: 2897696
[TBL] [Abstract][Full Text] [Related]
9. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
10. IL 2 receptor induction on human T lymphocytes: role for IL 2 and monocytes.
Wakasugi H; Bertoglio J; Tursz T; Fradelizi D
J Immunol; 1985 Jul; 135(1):321-7. PubMed ID: 2987347
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of the IL-2 receptor expressed on large granular lymphocytes from patients with abnormally expanded large granular lymphocytes. Implication of a non-Tac IL-2-binding peptide.
Hori T; Uchiyama T; Onishi R; Kamio M; Umadome H; Tamori S; Motoi T; Kodaka T; Uchino H
J Immunol; 1988 Jun; 140(12):4199-203. PubMed ID: 2836509
[TBL] [Abstract][Full Text] [Related]
12. Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells.
Kehrl JH; Dukovich M; Whalen G; Katz P; Fauci AS; Greene WC
J Clin Invest; 1988 Jan; 81(1):200-5. PubMed ID: 2826541
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.
Uchiyama T; Hori T; Tsudo M; Wano Y; Umadome H; Tamori S; Yodoi J; Maeda M; Sawami H; Uchino H
J Clin Invest; 1985 Aug; 76(2):446-53. PubMed ID: 2993359
[TBL] [Abstract][Full Text] [Related]
14. A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity.
Jacques Y; Le Mauff B; Boeffard F; Godard A; Soulillou JP
J Immunol; 1987 Oct; 139(7):2308-16. PubMed ID: 2821110
[TBL] [Abstract][Full Text] [Related]
15. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
16. Increased binding of IL-2 and increased IL-2 receptor mRNA synthesis are expressed by an NK-like cell line in response to IL-1.
Lubinski J; Fong TC; Babbitt JT; Ransone L; Yodoi JJ; Bloom ET
J Immunol; 1988 Mar; 140(6):1903-9. PubMed ID: 2831272
[TBL] [Abstract][Full Text] [Related]
17. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
[TBL] [Abstract][Full Text] [Related]
18. Antigen-specific and -nonspecific mitogenic signals in the activation of human T cell clones.
Nisbet-Brown ER; Lee JW; Cheung RK; Gelfand EW
J Immunol; 1987 Jun; 138(11):3713-9. PubMed ID: 2953789
[TBL] [Abstract][Full Text] [Related]
19. IL 2 alone is mitogenic only for Tac-positive lymphocytes in human peripheral blood.
Taylor DS; Kern JA; Nowell PC
J Immunol; 1986 Mar; 136(5):1620-4. PubMed ID: 3005396
[TBL] [Abstract][Full Text] [Related]
20. Abnormal expression of interleukin-2 receptor (Tac antigen) in adult T-cell leukemia.
Uchiyama T; Wano Y; Tsudo M; Umadome H; Hori T; Tamori S; Uchino H; Yodoi J; Maeda M; Kobayashi N
Princess Takamatsu Symp; 1984; 15():253-8. PubMed ID: 6100643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
